Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Onconetix (ONCO) Current Assets (2023 - 2025)

Historic Current Assets for Onconetix (ONCO) over the last 3 years, with Q3 2025 value amounting to $1.3 million.

  • Onconetix's Current Assets rose 2424.64% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year increase of 2424.64%. This contributed to the annual value of $950267.0 for FY2024, which is 8372.35% down from last year.
  • According to the latest figures from Q3 2025, Onconetix's Current Assets is $1.3 million, which was up 2424.64% from $930531.0 recorded in Q2 2025.
  • Onconetix's 5-year Current Assets high stood at $22.5 million for Q1 2023, and its period low was $930531.0 during Q2 2025.
  • Moreover, its 3-year median value for Current Assets was $2.4 million (2025), whereas its average is $5.8 million.
  • As far as peak fluctuations go, Onconetix's Current Assets crashed by 8901.64% in 2024, and later soared by 2424.64% in 2025.
  • Quarter analysis of 3 years shows Onconetix's Current Assets stood at $5.8 million in 2023, then crashed by 83.72% to $950267.0 in 2024, then surged by 37.02% to $1.3 million in 2025.
  • Its Current Assets was $1.3 million in Q3 2025, compared to $930531.0 in Q2 2025 and $2.4 million in Q1 2025.